オンコロジー分子診断の世界市場レポート 2024

オンコロジー分子診断の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には13.3%の年間複合成長率（CAGR）で79億9,000万米ドルに成長すると予想されます。予測期間で予想される成長は、リキッドバイオプシー技術の進歩、コンパニオン診断の出現、人工知能（AI）の組み込み、次世代シーケンサー（NGS）の応用範囲の拡大、バイオマーカーの継続的な進化によるものと考えられます。識別。予測期間中に予想される主な動向には、世界のアクセシビリティの向上、バイオマーカーの発見と検証における継続的な取り組み、規制枠組みの改良、技術プラットフォームの強化、患者中心のケアモデルの推進などが含まれます。

世界のがん患者数の増加は、オンコロジー分子診断市場の拡大に寄与する見込みです。米国がん協会の報告によると、2021年に米国では180万人の新規感染者と60万人ががん関連の死亡を記録しました。世界中で最も蔓延しているがんの種類である肺がん、前立腺がん、腸がん、および女性の乳がんは、新規がん症例全体の43%を占めています。その結果、世界のがん罹患率の急増により、今後数年間でオンコロジー分子診断市場の需要が高まると予想されます。

個別化医療に対する嗜好の高まりにより、オンコロジー分子診断市場の将来の成長が促進されると予想されます。個別化医療は、個々の患者に合わせて意思決定、実践、介入、薬物療法を調整する革新的な治療アプローチを表します。がん治療の分野では、オンコロジー分子診断は、個別化された治療計画の提供、薬剤選択の最適化、より正確で効果的な個別化された治療戦略の実施において重要な役割を果たします。このアプローチは最終的に患者の転帰を高め、全体的な生活の質を向上させます。米国に本拠を置く健康ニュース会社STATの報道によると、2022年10月の時点で75,000を超える遺伝子検査製品と300の個別化医薬品があることが示されています。したがって、個別化医療に対する需要の高まりがオンコロジー分子診断市場の成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のオンコロジー分子診断市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 機器
• 試薬
• その他の製品
• 世界のオンコロジー分子診断市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ポリメラーゼ連鎖反応（PCR）
• インサイチュハイブリダイゼーション（ISH）
• 等温核酸増幅技術（INNAT）
• チップとマイクロアレイ
• シーケンス
• 質量分析
• 転写媒介増幅（TMA）
• その他の技術
• 世界のオンコロジー分子診断市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 診断センター
• 学術研究機関
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のオンコロジー分子診断市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のオンコロジー分子診断市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オンコロジー分子診断市場の競合情勢
• オンコロジー分子診断市場の企業プロファイル
  • F. Hoffmann-La Roche AG
  • Bayer AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Danaher Corporation

第31章 その他の大手および革新的な企業

• Siemens Healthcare AG
• Becton Dickinson and Company
• Agilent Technologies Inc.
• HTG Molecular Diagnostics Inc.
• Hologic Inc.
• Illumina Inc.
• bioMerieux SA
• Charles River Laboratories India Pvt. Ltd.
• Beckman Coulter Inc.
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Qiagen NV
• Exact Sciences Corp.
• Bio-Techne Corporation
• OPKO Health Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Oncology molecular diagnostics involve procedures and services aimed at diagnosing cancers. These diagnostics utilize tests that examine genetic information, proteins, or related molecules, providing valuable insights into health or disease conditions.

The primary products within the oncology molecular diagnostics market include instruments, reagents, and other related items. Instruments play a crucial role in cancer diagnosis, employing various technologies such as polymerase chain reaction (PCR), in-situ hybridization (ISH), isothermal nucleic acid amplification technology (INNAT), chips and microarrays, sequencing, mass spectrometry, transcription-mediated amplification (TMA), among others. These technologies find applications across diverse end-users, including hospitals, diagnostic centers, academic and research institutes, and other healthcare institutions.

The oncology molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides oncology molecular diagnostics market statistics, including oncology molecular diagnostics industry global market size, regional shares, competitors with a oncology molecular diagnostics market share, detailed oncology molecular diagnostics segments, market trends and opportunities, and any further data you may need to thrive in the oncology molecular diagnostics industry. This oncology molecular diagnostics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oncology molecular diagnostics market size has grown rapidly in recent years. It will grow from $4.19 billion in 2023 to $4.84 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. The growth observed in the historic period can be credited to the introduction of early tests in the market, advancements in genomic profiling, the inception of next-generation sequencing (NGS), early identification of biomarkers, and the development of targeted therapies.

The oncology molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $7.99 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. The anticipated growth in the forecast period can be ascribed to progress in liquid biopsy techniques, the emergence of companion diagnostics, the incorporation of artificial intelligence (AI), the broadening applications of next-generation sequencing (NGS), and the ongoing evolution in biomarker identification. Major trends expected in the forecast period encompass increased global accessibility, ongoing efforts in biomarker discovery and validation, refinement of regulatory frameworks, enhancements in technological platforms, and the promotion of patient-centric care models.

The increase in the global number of cancer cases is poised to contribute to the expansion of the oncology molecular diagnostics market. In 2021, the USA witnessed 1.8 million new cases and 0.6 million cancer-related deaths, as reported by the American Cancer Society. The most prevalent cancer types worldwide-lung, prostate, bowel, and female breast cancer-accounted for 43% of all new cancer cases. Consequently, the surge in global cancer incidence rates is expected to drive demand for the oncology molecular diagnostics market in the coming years.

The growing preference for personalized medicine is anticipated to fuel the future growth of the oncology molecular diagnostics market. Personalized medicine represents an innovative medical treatment approach that tailors decisions, practices, interventions, and drug therapies to individual patients. In the realm of cancer care, oncology molecular diagnostics play a crucial role in delivering personalized treatment plans, optimizing drug selection, and implementing more precise, effective, and individualized treatment strategies. This approach ultimately enhances patient outcomes and improves the overall quality of life. As of October 2022, reports from the US-based health news company STAT indicated that there were over 75,000 genetic testing products and 300 personalized medicines. Hence, the rising demand for personalized medicine is a driving force behind the growth of the oncology molecular diagnostics market.

The substantial cost associated with molecular diagnostic tests poses a significant challenge to the oncology molecular diagnostics market. Molecular diagnostic testing in cancer care tends to be comparatively expensive, and the costs vary depending on the type of therapy. For instance, the molecular diagnostic test cost for non-small cell lung cancer monotherapy ranges from $10,000 to $20,000 per month, with further increases expected for combination therapies. Consequently, the high cost of molecular diagnostic tests is anticipated to impede the growth of the oncology molecular diagnostics market.

An important trend in the oncology molecular diagnostics market is the adoption of advanced genomics technology. Continuous progress in cancer genome sequencing technology, computational analysis, tumor modeling, and the introduction of modern research methods in cancer studies contribute to the early detection of cancer and its mutations. For example, in December 2021, Thermo Fisher Scientific Inc., a US-based company specializing in oncology molecular diagnostics, obtained FDA approval for a Next-Generation Sequencing (NGS)-based companion diagnostic test designed for non-small cell lung cancer patients. This test aids medical professionals in determining the suitability of Janssen Biotech's targeted medication RYBREVANT (amivantamab-vmjw) for these patients.

Leading companies in the oncology molecular diagnostics market are directing their efforts toward innovative products, such as oncology liquid biopsy products, to enhance market revenues. Oncology liquid biopsy products serve as advanced diagnostic tools and tests facilitating the non-invasive detection and monitoring of cancer by analyzing various biomarkers and genetic material. In July 2022, BillionToOne Inc., a US-based biotechnology company specializing in molecular diagnostics and genetic testing, launched oncology liquid biopsy products, namely NorthStar Select and NorthStar Response. NorthStar Select is a comprehensive somatic mutation profiling panel for cancer, identifying actionable mutations with a significant limit of detection due to BillionToOne's proprietary molecular counting method, known as quantitative counting templates (QCTs). NorthStar Response is a tissue-neutral, methylation-based treatment response monitoring test, providing an accurate estimation of the burden of methylation circulating tumor DNA (ctDNA) using molecular counting technologies.

In September 2021, HealthCare Global Enterprises Limited, an India-based oncology care provider, acquired Oncology hospital labs and the clinical trial business from Strand Lifesciences. This acquisition enhances its in-house diagnostic and research capabilities, fostering greater awareness and adoption of cancer diagnostics. Strand Lifesciences is an India-based company specializing in oncology and technology.

Major companies operating in the oncology molecular diagnostics market report are F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMerieux SA, Charles River Laboratories India Pvt. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies lnc., TBG Diagnostics Limited, The Genetics of Cancer, Genomic Health Inc.

North America was the largest region in the oncology molecular diagnostics market in 2023. Western Europe was the second largest region in the global oncology molecular diagnostics market report. The regions covered in the oncology molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The oncology molecular diagnostics market includes revenues earned by oncology molecular diagnostics tools and kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncology Molecular Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncology molecular diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oncology molecular diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Instruments; Reagents; Other Products
• 2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips & Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Other Technologies
• 3) By End User: Hospitals; Diagnostic Centers; Academic & Research Institutes; Other End Users
• Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oncology Molecular Diagnostics Market Characteristics

3. Oncology Molecular Diagnostics Market Trends And Strategies

4. Oncology Molecular Diagnostics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Oncology Molecular Diagnostics Market Size and Growth

• 5.1. Global Oncology Molecular Diagnostics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Oncology Molecular Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Oncology Molecular Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Oncology Molecular Diagnostics Market Segmentation

• 6.1. Global Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Instruments
• Reagents
• Other Products
• 6.2. Global Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Polymerase Chain Reaction (PCR)
• In-situ Hybridization (ISH)
• Isothermic Nucleic Acid Amplification Technology (INNAT)
• Chips & Microarrays
• Sequencing
• Mass Spectroscopy
• Transcription Mediated Amplification (TMA)
• Other Technologies
• 6.3. Global Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Diagnostic Centers
• Academic & Research Institutes
• Other End Users

7. Oncology Molecular Diagnostics Market Regional And Country Analysis

• 7.1. Global Oncology Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Oncology Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Oncology Molecular Diagnostics Market

• 8.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Oncology Molecular Diagnostics Market

• 9.1. China Oncology Molecular Diagnostics Market Overview
• 9.2. China Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Oncology Molecular Diagnostics Market

• 10.1. India Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Oncology Molecular Diagnostics Market

• 11.1. Japan Oncology Molecular Diagnostics Market Overview
• 11.2. Japan Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Oncology Molecular Diagnostics Market

• 12.1. Australia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Oncology Molecular Diagnostics Market

• 13.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Oncology Molecular Diagnostics Market

• 14.1. South Korea Oncology Molecular Diagnostics Market Overview
• 14.2. South Korea Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Oncology Molecular Diagnostics Market

• 15.1. Western Europe Oncology Molecular Diagnostics Market Overview
• 15.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Oncology Molecular Diagnostics Market

• 16.1. UK Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Oncology Molecular Diagnostics Market

• 17.1. Germany Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Oncology Molecular Diagnostics Market

• 18.1. France Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Oncology Molecular Diagnostics Market

• 19.1. Italy Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Oncology Molecular Diagnostics Market

• 20.1. Spain Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Oncology Molecular Diagnostics Market

• 21.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
• 21.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Oncology Molecular Diagnostics Market

• 22.1. Russia Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Oncology Molecular Diagnostics Market

• 23.1. North America Oncology Molecular Diagnostics Market Overview
• 23.2. North America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Oncology Molecular Diagnostics Market

• 24.1. USA Oncology Molecular Diagnostics Market Overview
• 24.2. USA Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Oncology Molecular Diagnostics Market

• 25.1. Canada Oncology Molecular Diagnostics Market Overview
• 25.2. Canada Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Oncology Molecular Diagnostics Market

• 26.1. South America Oncology Molecular Diagnostics Market Overview
• 26.2. South America Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Oncology Molecular Diagnostics Market

• 27.1. Brazil Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Oncology Molecular Diagnostics Market

• 28.1. Middle East Oncology Molecular Diagnostics Market Overview
• 28.2. Middle East Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Oncology Molecular Diagnostics Market

• 29.1. Africa Oncology Molecular Diagnostics Market Overview
• 29.2. Africa Oncology Molecular Diagnostics Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Oncology Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Oncology Molecular Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Oncology Molecular Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Oncology Molecular Diagnostics Market Competitive Landscape
• 30.2. Oncology Molecular Diagnostics Market Company Profiles
  • 30.2.1. F. Hoffmann-La Roche AG
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Bayer AG
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Thermo Fisher Scientific Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Abbott Laboratories
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Danaher Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Oncology Molecular Diagnostics Market Other Major And Innovative Companies

• 31.1. Siemens Healthcare AG
• 31.2. Becton Dickinson and Company
• 31.3. Agilent Technologies Inc.
• 31.4. HTG Molecular Diagnostics Inc.
• 31.5. Hologic Inc.
• 31.6. Illumina Inc.
• 31.7. bioMerieux SA
• 31.8. Charles River Laboratories India Pvt. Ltd.
• 31.9. Beckman Coulter Inc.
• 31.10. Sysmex Corporation
• 31.11. Bio-Rad Laboratories Inc.
• 31.12. Qiagen N.V.
• 31.13. Exact Sciences Corp.
• 31.14. Bio-Techne Corporation
• 31.15. OPKO Health Inc.

32. Global Oncology Molecular Diagnostics Market Competitive Benchmarking

33. Global Oncology Molecular Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Oncology Molecular Diagnostics Market

35. Oncology Molecular Diagnostics Market Future Outlook and Potential Analysis

• 35.1 Oncology Molecular Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Oncology Molecular Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Oncology Molecular Diagnostics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer